What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Law
- Health care
Nancy A. Rigotti mostly deals with Internal medicine, Abstinence, Bupropion, Randomized controlled trial and Environmental health.
Her Abstinence research integrates issues from Cotinine and Emergency medicine.
Her work carried out in the field of Bupropion brings together such families of science as Relapse prevention, Placebo, Nicotine withdrawal and Rate ratio.
Her Randomized controlled trial study incorporates themes from Odds ratio and Clinical trial.
She combines subjects such as Response rate, Odds and Health policy with her study of Environmental health.
Her Anesthesia research focuses on subjects like Nicotine, which are linked to Prospective cohort study.
Her most cited work include:
- Efficacy of Varenicline, an 42 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation A Randomized Controlled Trial (1288 citations)
- Interventions for smoking cessation in hospitalised patients (513 citations)
- Initial symptoms of nicotine dependence in adolescents (491 citations)
What are the main themes of her work throughout her whole career to date?
Her primary scientific interests are in Family medicine, Randomized controlled trial, Abstinence, Environmental health and Internal medicine.
Nancy A. Rigotti interconnects Tobacco control, Psychological intervention, Telephone counseling, Intervention and Health care in the investigation of issues within Family medicine.
Her studies in Randomized controlled trial integrate themes in fields like Nicotine patch, Physical therapy, Clinical trial and Varenicline.
Her Abstinence research includes elements of Nicotine replacement therapy, Nicotine and Anesthesia.
Her Environmental health research incorporates elements of Logistic regression, Odds, Public health and Tobacco use.
Her Internal medicine study which covers Placebo that intersects with Bupropion.
She most often published in these fields:
- Family medicine (22.35%)
- Randomized controlled trial (21.23%)
- Abstinence (18.16%)
What were the highlights of her more recent work (between 2017-2021)?
- Randomized controlled trial (21.23%)
- Family medicine (22.35%)
- Abstinence (18.16%)
In recent papers she was focusing on the following fields of study:
Her primary areas of investigation include Randomized controlled trial, Family medicine, Abstinence, Internal medicine and Nicotine.
Her study in Randomized controlled trial is interdisciplinary in nature, drawing from both Psychological intervention, Psychiatry, Intervention, Quit smoking and Nicotine replacement therapy.
Her Abstinence research is multidisciplinary, relying on both Logistic regression, Clinical trial and Smokeless tobacco.
Her Internal medicine research is multidisciplinary, incorporating elements of Standard treatment and MEDLINE.
Nancy A. Rigotti has included themes like Tobacco control and Environmental health in her Nicotine study.
Her research in Environmental health intersects with topics in Tobacco use and Risk factor.
Between 2017 and 2021, her most popular works were:
- Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study (83 citations)
- 2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. (68 citations)
- Association of E-Cigarette Use With Smoking Cessation Among Smokers Who Plan to Quit After a Hospitalization: A Prospective Study. (31 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Law
Nancy A. Rigotti focuses on Family medicine, Abstinence, Randomized controlled trial, Nicotine and Environmental health.
Her Family medicine study deals with MEDLINE intersecting with Intensive care medicine, Lung injury and Clinical trial.
Her work investigates the relationship between Abstinence and topics such as Odds ratio that intersect with problems in Cohort, Attendance and Comorbidity.
Randomized controlled trial is a subfield of Internal medicine that Nancy A. Rigotti studies.
Her research integrates issues of Tobacco use, Cause of death and Population health, Public health, Health promotion in her study of Environmental health.
Her study in the field of Tobacco control is also linked to topics like Chess endgame.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
